Literature DB >> 6296654

Differences in the forskolin activation of adenylate cyclases in wild-type and variant lymphoma cells.

R B Clark, T J Goka, D A Green, R Barber, R W Butcher.   

Abstract

The ability of the diterpene forskolin to stimulate cyclic AMP accumulation in intact cell and membrane preparations of wild-type S49 lymphoma cells (WT) and a number of variants has been confirmed. Additionally, a number of salient new findings have emerged: (a) A time delay in forskolin stimulation of cyclic AMP accumulation and adenylate cyclase (t 1/2 approximately equal to 1.5 min) occurred in all hormone-sensitive WT and variant cell and membrane preparations tested. (b) The time delay was missing in the adenylate cyclase-deficient variant (cyc-) of the S49 lymphoma cell, which also lacks functional adenylate cyclase-coupling proteins. (c) The simultaneous addition of epinephrine and forskolin to WT cells or to membrane preparations eliminated the time delay. (d) Forskolin stimulation of intact WT cells did not appear to desensitize adenylate cyclase. (e) The activation of WT adenylate cyclase by forskolin was biphasic with respect to concentration, with both high- and low-affinity components being apparent. In cyc-, only the low-affinity component was detected.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6296654

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  16 in total

1.  Effects of forskolin on bone resorption in the absence and presence of parathyroid hormone and calcitonin.

Authors:  H H Conaway; R L Abraham; C L Wadkins
Journal:  Calcif Tissue Int       Date:  1987-05       Impact factor: 4.333

2.  Increase of adenylate cyclase catalytic-unit activity by dexamethasone in rat osteoblast-like cells.

Authors:  R Rizzoli; V von Tscharner; H Fleisch
Journal:  Biochem J       Date:  1986-07-15       Impact factor: 3.857

3.  Forskolin refractoriness. Exposure to the diterpene alters guanine nucleotide-dependent adenylate cyclase and calcium-uptake activity of cells cultured from the rat aorta.

Authors:  J F Krall; N Jamgotchian
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

4.  Evidence for a two-site model of forskolin action in frog urinary bladder.

Authors:  M Svelto; V Casavola; G Valenti; J Bourguet
Journal:  Pflugers Arch       Date:  1987-08       Impact factor: 3.657

5.  Photoaffinity labeling of the beta-adrenergic receptor from cultured lymphoma cells with [125I]iodoazidobenzylpindolol: loss of the label with desensitization.

Authors:  A Rashidbaigi; A E Ruoho; D A Green; R B Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

6.  Quantification of signalling components and amplification in the beta-adrenergic-receptor-adenylate cyclase pathway in isolated adult rat ventricular myocytes.

Authors:  S R Post; R Hilal-Dandan; K Urasawa; L L Brunton; P A Insel
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

7.  Characterization of the homologous and heterologous desensitization of rat Leydig-tumour-cell adenylate cyclase.

Authors:  C J Dix; A D Habberfield; B A Cooke
Journal:  Biochem J       Date:  1984-06-15       Impact factor: 3.857

8.  Vasoactive-intestinal-polypeptide-stimulated adenosine 3',5'-cyclic monophosphate accumulation in GH3 pituitary tumour cells. Reversal of desensitization by forskolin.

Authors:  S Guild; A H Drummond
Journal:  Biochem J       Date:  1984-08-01       Impact factor: 3.857

9.  Ca2+ channel currents in rat sensory neurones: interaction between guanine nucleotides, cyclic AMP and Ca2+ channel ligands.

Authors:  A C Dolphin
Journal:  J Physiol       Date:  1991-01       Impact factor: 5.182

10.  Characterization of forskolin binding sites in rat brain membranes using [14,15-3H]14,15-dihydroforskolin as a ligand.

Authors:  K Schmidt; R Munshi; H P Baer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-02       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.